Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

NCT01445340 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Mycosis Fungoides
Cutaneous T-Cell Lymphoma
Neoplasms

Interventions

DRUG: Romidepsin (FR901228)

Sponsor

National Cancer Institute (NCI)